Thus, we proposed the reasonable hypothesis that the miR-129-5p/PEG3 axis might play a part in liver fibrosis in NASH through regulating the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.